01
PGT-A / ANEUPLOIDY
Pre-Implantation Genetic Testing for Aneuploidy
Using a Next Generation Sequencing platform to assess embryo biopsies for chromosomal abnormalities — providing the precision needed to identify which embryos have the best chance of leading to a healthy pregnancy.
02
PGT-M / MONOGENIC
Pre-Implantation Genetic Testing for Monogenic Conditions
Assesses embryo biopsies for hereditary variants from parental origin. Custom probes are developed in collaboration with patients to achieve optimal accuracy — and may reduce the need for additional family member testing.
03
PGT-SR / STRUCTURAL
Pre-Implantation Genetic Testing for Structural Rearrangements
Assesses embryo biopsies for inherited abnormal karyotypes. Work directly with Conceivium to evaluate your specific case and develop a tailored testing strategy.
04
REPROMAP / MICROBIOME
Microbiome Assessment Panel
ReproMAP uses Next Generation Sequencing for metagenomic analysis of vaginal swabs, menstrual blood, and semen. Species-level identification ensures we accurately characterize microbes — going beyond what genus-level testing can detect.
FemaleMAP assesses vaginal swab and menstrual blood samples. PartnerMAP adds semen analysis for a fuller picture of the fertility couple.
05
REPROMMUNITY / IMMUNE
Immune Profile Analysis
Reprommunity uses qPCR, flow cytometry, and ELISA techniques to evaluate the immunogenetics and immune cell profiles of both partners — determining the optimal conditions for conception.
Detects immune cell ratios, cytokine ratios, T cell response, immune compatibility, parental immune genotypes, and parental immunogenetic overlaps.
06
REPRODUO / BUNDLED PACKAGE
ReproDUO
Combines our ReproMAP (FemaleMAP) test with Reprommunity to provide a complete snapshot of the couple’s microbiome and immune systems — in one comprehensive bundle.
The most efficient way to understand both biological systems that influence fertility outcomes.
07
FSH RECEPTOR / STIMULATION
FSH Receptor Test
Uses qPCR technology to determine a patient’s optimal response to FSH medications — helping to optimize response during medical stimulation and reduce the risk of low-response cycles.
08
GMP / METABOLIC
Genetic Metabolic Profile
FTO and MC4R Test. Uses qPCR technology to determine a patient’s specific genotype and assess their genetic predisposition to metabolic challenges — evaluating how the body responds to and produces hunger hormones.